139 related articles for article (PubMed ID: 18084979)
1. Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers.
Migita T; Mukaida K; Kawamoto M; Kobayashi M; Nishino I; Yuget O
Anaesth Intensive Care; 2007 Dec; 35(6):894-8. PubMed ID: 18084979
[TBL] [Abstract][Full Text] [Related]
2. Effects of propofol on calcium homeostasis in human skeletal muscle.
Migita T; Mukaida K; Hamada H; Kobayashi M; Nishino I; Yuge O; Kawamoto M
Anaesth Intensive Care; 2009 May; 37(3):415-25. PubMed ID: 19499861
[TBL] [Abstract][Full Text] [Related]
3. Analysis of human cultured myotubes responses mediated by ryanodine receptor 1.
Kobayashi M; Mukaida K; Migita T; Hamada H; Kawamoto M; Yuge O
Anaesth Intensive Care; 2011 Mar; 39(2):252-61. PubMed ID: 21485675
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
Wehner M; Rueffert H; Koenig F; Olthoff D
Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166
[TBL] [Abstract][Full Text] [Related]
5. Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes.
Fruen BR; Mickelson JR; Roghair TJ; Litterer LA; Louis CF
Anesthesiology; 1995 May; 82(5):1274-82. PubMed ID: 7741303
[TBL] [Abstract][Full Text] [Related]
6. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
[TBL] [Abstract][Full Text] [Related]
7. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47.
Migita T; Mukaida K; Hamada H; Yasuda T; Haraki T; Nishino I; Murakami N; Kawamoto M
J Anesth; 2009; 23(3):341-6. PubMed ID: 19685112
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation.
Wehner M; Rueffert H; Koenig F; Neuhaus J; Olthoff D
Clin Genet; 2002 Aug; 62(2):135-46. PubMed ID: 12220451
[TBL] [Abstract][Full Text] [Related]
11. Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.
Wehner M; Rueffert H; Koenig F; Olthoff D
Genet Test; 2003; 7(3):203-11. PubMed ID: 14641996
[TBL] [Abstract][Full Text] [Related]
12. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.
Ducreux S; Zorzato F; Müller C; Sewry C; Muntoni F; Quinlivan R; Restagno G; Girard T; Treves S
J Biol Chem; 2004 Oct; 279(42):43838-46. PubMed ID: 15299003
[TBL] [Abstract][Full Text] [Related]
13. Effects of Remimazolam and Propofol on Ca
Watanabe T; Miyoshi H; Noda Y; Narasaki S; Morio A; Toyota Y; Kimura H; Mukaida K; Yasuda T; Tsutsumi YM
Biomed Res Int; 2021; 2021():8845129. PubMed ID: 33490280
[TBL] [Abstract][Full Text] [Related]
14. Effects of Remimazolam on Intracellular Calcium Dynamics in Myotubes Derived from Patients with Malignant Hyperthermia and Functional Analysis of Type 1 Ryanodine Receptor Gene Variants.
Miyoshi H; Otsuki S; Mukaida K; Kido K; Sumii A; Ikeda T; Noda Y; Yasuda T; Narasaki S; Kato T; Kamiya S; Horikawa YT; Tsutsumi YM
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002952
[TBL] [Abstract][Full Text] [Related]
15. Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes.
Brinkmeier H; Krämer J; Krämer R; Iaizzo PA; Baur C; Lehmann-Horn F; Rüdel R
Br J Anaesth; 1999 Dec; 83(6):855-61. PubMed ID: 10700782
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
[TBL] [Abstract][Full Text] [Related]
17. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
Censier K; Urwyler A; Zorzato F; Treves S
J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
[TBL] [Abstract][Full Text] [Related]
18. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.
Dietze B; Henke J; Eichinger HM; Lehmann-Horn F; Melzer W
J Physiol; 2000 Aug; 526 Pt 3(Pt 3):507-14. PubMed ID: 10922003
[TBL] [Abstract][Full Text] [Related]
20. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.
Barrientos GC; Feng W; Truong K; Matthaei KI; Yang T; Allen PD; Lopez JR; Pessah IN
J Biol Chem; 2012 Jan; 287(4):2863-76. PubMed ID: 22139840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
